Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Harder

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Periodontology|May 6, 2024
Dynamic analyses of a soft tissue-implant interface: Biological responses to immediate versus delayed dental implantsFabiana Aellos, Joseph A Grauer, Kasidy G Harder, et al.
Neuro-Oncology|June 14, 2018
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistanceDavid S Hersh, Bryan G Harder, Alison Roos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneMark J Canet, Matthew D Merrell, Bryan G Harder, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
The International Journal of Occupational and Environmental Medicine|April 27, 2016
Physical Activity and Exercise Interventions in the Workplace Impacting Work Outcomes: A Stakeholder-Centered Best Evidence Synthesis of Systematic ReviewsM I White, C E Dionne, O Wärje, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
The International Journal of Occupational and Environmental Medicine|January 17, 2016
Mental Health Interventions in the Workplace and Work Outcomes: A Best-Evidence Synthesis of Systematic ReviewsS L Wagner, C Koehn, M I White, et al.
The International Journal of Occupational and Environmental Medicine|October 27, 2015
Social Support and Supervisory Quality Interventions in the Workplace: A Stakeholder-Centered Best-Evidence Synthesis of Systematic Reviews on Work OutcomesS L Wagner, M I White, I Z Schultz, et al.
Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Periodontology|May 6, 2024
Dynamic analyses of a soft tissue-implant interface: Biological responses to immediate versus delayed dental implantsFabiana Aellos, Joseph A Grauer, Kasidy G Harder, et al.
Neuro-Oncology|June 14, 2018
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistanceDavid S Hersh, Bryan G Harder, Alison Roos, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 29, 2014
Identification of a functional antioxidant response element within the eighth intron of the human ABCC3 geneMark J Canet, Matthew D Merrell, Bryan G Harder, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
The International Journal of Occupational and Environmental Medicine|April 27, 2016
Physical Activity and Exercise Interventions in the Workplace Impacting Work Outcomes: A Stakeholder-Centered Best Evidence Synthesis of Systematic ReviewsM I White, C E Dionne, O Wärje, et al.
Journal of Clinical Medicine|February 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS SyndromeDavid B Beck, Maël Heiblig, Sinisa Savic, et al.
The International Journal of Occupational and Environmental Medicine|January 17, 2016
Mental Health Interventions in the Workplace and Work Outcomes: A Best-Evidence Synthesis of Systematic ReviewsS L Wagner, C Koehn, M I White, et al.
The International Journal of Occupational and Environmental Medicine|October 27, 2015
Social Support and Supervisory Quality Interventions in the Workplace: A Stakeholder-Centered Best-Evidence Synthesis of Systematic Reviews on Work OutcomesS L Wagner, M I White, I Z Schultz, et al.
Blood Advances|August 8, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosisStephen T Oh, Ruben A Mesa, Claire N Harrison, et al.
Pageof 4